Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
Hospitalizations Reduced With Monoclonal Antibody for Moderate-to-Severe Atopic Dermatitis
06/17/2022
Jolynn Tumolo
Patients treated with a monoclonal antibody for moderate-to-severe atopic dermatitis (AD) had lower rates of all-cause and AD-related hospitalizations, findings showed.
Patients treated with a monoclonal antibody for moderate-to-severe atopic dermatitis (AD) had lower rates of all-cause and AD-related hospitalizations, findings showed.
Patients treated with a...
06/17/2022
First Report Managed Care
News
Most States Have Rules for Unwanted Drug Disposal, But Few Provide Funding
06/16/2022
Jolynn Tumolo
“Most states have passed a statute relating to drug disposal from the general public as of May 2022, and their characteristics varied widely,” wrote study authors.
“Most states have passed a statute relating to drug disposal from the general public as of May 2022, and their characteristics varied widely,” wrote study authors.
“Most states have passed a...
06/16/2022
Pharmacy Learning Network
News
Screening Scale Flags Children, Adolescents With High Likelihood of Narcolepsy
06/16/2022
Jolynn Tumolo
Researchers reported the benefit of the Pediatric Narcolepsy Screening Questionnaire in identifying children with narcolepsy or other sleep problems.
Researchers reported the benefit of the Pediatric Narcolepsy Screening Questionnaire in identifying children with narcolepsy or other sleep problems.
Researchers reported the benefit...
06/16/2022
First Report Managed Care
News
Chronic PTSD, Comorbid Depression Symptoms Improved With Ketamine
06/16/2022
Jolynn Tumolo
Repeated ketamine infusions over 2 weeks were associated with large-magnitude improvement in post-traumatic stress disorder (PTSD) symptoms compared with a psychoactive placebo in individuals with chronic PTSD.
Repeated ketamine infusions over 2 weeks were associated with large-magnitude improvement in post-traumatic stress disorder (PTSD) symptoms compared with a psychoactive placebo in individuals with chronic PTSD.
Repeated ketamine infusions over...
06/16/2022
Psych Congress Network
News
Cortical Thinning May Begin After Psychosis Onset in Patients With Schizophrenia
06/16/2022
Jolynn Tumolo
In people with schizophrenia, cortical thickness appears to be unaltered at the onset of psychosis but to grow thinner throughout the illness course.
In people with schizophrenia, cortical thickness appears to be unaltered at the onset of psychosis but to grow thinner throughout the illness course.
In people with schizophrenia,...
06/16/2022
Psych Congress Network
News
Pharmacist-Led Antiretroviral Stewardship Program Cuts Errors by One-Third
06/16/2022
Jolynn Tumolo
Findings showed the number of uncorrected antiretroviral therapy errors was significantly reduced by a pharmacist-led antiretroviral stewardship program.
Findings showed the number of uncorrected antiretroviral therapy errors was significantly reduced by a pharmacist-led antiretroviral stewardship program.
Findings showed the number of...
06/16/2022
Pharmacy Learning Network
News
Eye Drops Recalled
06/16/2022
Jolynn Tumolo
A prescription medication used to treat signs and symptoms of dry eye disease is being voluntarily recalled by Novartis Pharmaceuticals Corporation.
A prescription medication used to treat signs and symptoms of dry eye disease is being voluntarily recalled by Novartis Pharmaceuticals Corporation.
A prescription medication used...
06/16/2022
Pharmacy Learning Network
News
As Understanding of ALS Grows, Novel Therapies Anticipated
06/15/2022
Jolynn Tumolo
Since the discovery of SOD1 nearly 30 years ago, the identification of genes linked with amyotrophic lateral sclerosis (ALS) has progressed from a fairly slow start to the current period of quickly emerging insight.
Since the discovery of SOD1 nearly 30 years ago, the identification of genes linked with amyotrophic lateral sclerosis (ALS) has progressed from a fairly slow start to the current period of quickly emerging insight.
Since the discovery of SOD1...
06/15/2022
Neurology
News
RAAS Inhibitors May Lower Risk of Intracranial Aneurysm Rupture
06/15/2022
Jolynn Tumolo
Renin-angiotensin-aldosterone system (RAAS) inhibitors were linked with a significant decreased rupture risk in patients with hypertension and intracranial aneurysms, according to findings from a retrospective study published in Hypertension.
Renin-angiotensin-aldosterone system (RAAS) inhibitors were linked with a significant decreased rupture risk in patients with hypertension and intracranial aneurysms, according to findings from a retrospective study published in Hypertension.
Renin-angiotensin-aldosterone...
06/15/2022
Neurology
News
ADHD Medication Linked With Lower Unemployment Risk, Particularly In Women
06/14/2022
Jolynn Tumolo
Pharmacological treatment for ADHD was associated with a lower risk of long-term unemployment, especially in women, in a population-based cohort study in Sweden.
Pharmacological treatment for ADHD was associated with a lower risk of long-term unemployment, especially in women, in a population-based cohort study in Sweden.
Pharmacological treatment for...
06/14/2022
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use